Relationship of predialytic intact parathyroid hormone on secondary hyperparathyroidism in chronic maintenance haemodialysis patients

被引:1
|
作者
Etoh, S
Murata, T
Hasegawa, Y
Miyahara, Y
Ishimura, A
Abe, Y
Noda, R
Ogahara, S
Kaneoka, H
Saito, T
机构
[1] Fukuoka Univ, Sch Med, Dept Internal Med, Div Nephrol & Rheumatol,Jonan Ku, Fukuoka 8140180, Japan
[2] Kawanami Hosp Kidney Ctr, Fukuoka, Japan
关键词
haemodialysis; intact-parathyroid hormone; parathyroid ultrasonography; predialysis; risk factor; secondary hyperparathyroidism;
D O I
10.1111/j.1440-1797.2004.00248.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Methods and Results: In order to clarify the predialytic factors influencing the onset of secondary hyperparathyroidism (SHPT) in patients on chronic maintenance haemodialysis, the time-course changes of serum levels of intact-PTH (i-PTH) during haemodialysis for 5 years were investigated. The subjects were 69 non-diabetic patients who had a serum aluminium level of less than 1.85 nmol/L at the end of observation. Patients were divided into two groups based on i-PTH levels obtained at the start of dialysis; the high group (H group) consisted of patients whose i-PTH levels were more than 22.00 pmol/L, the low group (L group) had levels less than 22.00 pmol/L. In the H group, i-PTH was 41.46 +/- 2.87 pmol/L at the start of dialysis (vs L group, P < 0.0001) and 15.82 +/- 2.85 pmol/L after haemodialysis initiation. In the L group, i-PTH levels did not significantly change and was 11.69 +/- 2.50 pmol/L 12 months after the start of dialysis (at the 12th month). However, at the 60th month, the i-PTH level was 33.24 +/- 5.30 pmol/L in the H group, and 9.85 +/- 2.13 pmol/L in the L group (P < 0.005). Conclusion: It is suggested that control of i-PTH levels in the predialytic period may be important to suppress SHPT throughout haemodialysis.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [1] Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy
    Fujimori, A
    Sakai, M
    Yoshiya, K
    Shin, J
    Kim, JI
    Inaba, Y
    Miyamoto, T
    Inoue, S
    Fukagawa, M
    THERAPEUTIC APHERESIS AND DIALYSIS, 2004, 8 (06) : 474 - 479
  • [2] Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
    Li Fang
    Bing Tang
    Dawei Hou
    Meijuan Meng
    Mingxia Xiong
    Junwei Yang
    BMC Nephrology, 16
  • [3] Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
    Fang, Li
    Tang, Bing
    Hou, Dawei
    Meng, Meijuan
    Xiong, Mingxia
    Yang, Junwei
    BMC NEPHROLOGY, 2015, 16
  • [4] Relationship Between the Weight of Parathyroid Glands and Their Secretion of Parathyroid Hormone in Hemodialysis Patients With Secondary Hyperparathyroidism
    Kakuta, Takatoshi
    Tanaka, Reika
    Kanai, Genta
    Miyamoto, Yoshiyasu
    Inagaki, Miho
    Suzuki, Hajime
    Fukagawa, Masafumi
    Saito, Akira
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (05) : 385 - 390
  • [5] Diagnosis of secondary hyperparathyroidism in a pony using intact parathyroid hormone radioimmunoassay
    Benders, NA
    Junker, K
    Wensing, T
    van den Ingh, TSGAM
    van der Kolk, JH
    VETERINARY RECORD, 2001, 149 (06) : 185 - 187
  • [6] RIGHT INDEX FINGER RADIOGRAPHIC MANIFESTATIONS OF SECONDARY HYPERPARATHYROIDISM AND INTACT PARATHYROID-HORMONE LEVELS IN PATIENTS ON CHRONIC-HEMODIALYSIS
    POTGIETER, CD
    MENTIS, H
    KIDNEY INTERNATIONAL, 1991, 39 (02) : 361 - 361
  • [7] Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism
    Chou, FF
    Lee, CH
    Chen, JB
    Hsu, KT
    Sheen-Chen, SM
    ARCHIVES OF SURGERY, 2002, 137 (03) : 341 - 344
  • [8] The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation
    Tabibzadeh, Nahid
    Karaboyas, Angelo
    Robinson, Bruce M.
    Csomor, Philipp A.
    Spiegel, David M.
    Evenepoel, Pieter
    Jacobson, Stefan H.
    Urena-Torres, Pablo-Antonio
    Fukagawa, Masafumi
    Al Salmi, Issa
    Liang, Xinling
    Pisoni, Ronald L.
    Young, Eric W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (01) : 160 - 169
  • [9] INTACT PARATHYROID-HORMONE IN PRIMARY HYPERPARATHYROIDISM
    FLENTJE, D
    SCHMIDTGAYK, H
    FISCHER, S
    STERN, J
    BLIND, E
    BUHR, H
    HERFARTH, C
    BRITISH JOURNAL OF SURGERY, 1990, 77 (02) : 168 - 172
  • [10] Primary Hyperparathyroidism With Undetectable Intact Parathyroid Hormone
    Song, Zhixing
    McMullin, Jessica
    Huls, Forest
    Rosenthal, Richard
    Bantu, Sravani
    Wu, Christopher
    Chen, Herbert
    Lindeman, Brenessa
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2024, 17